Wolters Kluwer divests pharmacy business

ALPHEN AAN DEN RIJN, Netherlands — Wolters Kluwer will sell its pharma-related business, the market research firm said Wednesday.

The company’s pharmacy business, which includes the brands Source and Adis, includes marketing and publications services, business intelligence products and advanced analytical tools and services to life science professionals.

“The planned divestment of the pharmacy business will focus our health division on taking full advantage of our leading positions in professional information and clinical decision support solutions, one of the fastest growing areas of health, to deliver enhanced value to our stakeholders,” Wolters Kluwer chairman and CEO Nancy McKinstry said.

The company said that Lazard Middle Market and William Blair & Co. were acting as financial advisers and that the deal would close shortly after the end of the year, but it did not name a buyer.